Cyclerion Therapeutics Inc. (NASDAQ: CYCN)
$3.1600
-0.0400 ( +1.28% ) 68.0K
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Market Data
Open
$3.1600
Previous close
$3.2000
Volume
68.0K
Market cap
$9.00M
Day range
$3.0320 - $3.3950
52 week range
$1.2700 - $9.4699
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 1 | Mar 11, 2024 |
10-k | Annual reports | 96 | Mar 05, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
3 | Insider transactions | 1 | Dec 11, 2023 |
3 | Insider transactions | 1 | Dec 07, 2023 |
3/a | Insider transactions | 1 | Dec 07, 2023 |
4 | Insider transactions | 1 | Dec 04, 2023 |
4 | Insider transactions | 1 | Dec 04, 2023 |
8-k | 8K-related | 13 | Dec 04, 2023 |